Our integrated analyses identified the key pathways in patients with PAH, including cAMP, ECM-receptor interaction, AMPK, hypoxia-inducible factor 1-α, and the PI3K-Akt signaling pathways [33]. The gene discussed is AKT1; the disease is pulmonary arterial hypertension.